CARLOS R. HAMILTON, JR., MD, FACE
Professor of Internal medicine
University of Texas Houston Medical School
Carlos R. Hamilton, Jr., MD, FACE, has practiced clinical endocrinology and internal medicine, and he is the executive vice president of the University of Texas Health Science Center at Houston and a professor of internal medicine at the UT Houston Medical School. After graduating from Baylor College of Medicine, he completed his internship and residency at the Johns Hopkins Hospital, an endocrine fellowship at the Massachusetts General Hospital, and was chief resident in medicine at Hopkins. He was on the full-time faculty at Hopkins before serving two years as an endocrinologist at the Wilford Hall USAF Medical Center in San Antonio. He was in private practice for 26 years and was a clinical professor of medicine at Baylor College of Medicine before assuming his present position.
Dr. Hamilton has been active in medical organizations primarily as an advocate for medical practice and patient's rights. He has been a member of the AACE board of directors and served as chair of the AACE legislative and regulatory committee. He has also served as president of the Texas Society of Internal Medicine, the Harris County Medical Society and as chair of the Texas Medical Association Political Action Committee. He has served as a trustee of the American Society of Internal Medicine, as a member of the ACP-ASIM Health and Public Policy Committee and as a member of the AMA Federation Advisory Committee. He served as the 2004–2005 AACE president and as a trustee of the American College of Endocrinology. He is a past president on the AACE board of directors and president-elect of the American College of Endocrinology. He is a member of the practicing physicians advisory council to the US Secretary of Health and Human Services for issues related to the Center of Medicare and Medicaid Services. He also serves on the health, medicine and research committee of the World Anti-Doping Agency, which oversees the international prohibitions of the use of hormones and performance enhancing substances in athletic competition.
Oregon Health and Sciences University Dr. David Cook is currently Professor of Medicine and Interim Chief of the Division of Endocrinology at Oregon Health and Science University (OHSU) in Portland, Oregon. He has been involved in clinical research for over thirty years at this institution. Before (OHSU) he had clinical training at the Mayo Clinic in Rochester, Minnesota and at the University of Chicago, Chicago, Illinois. His interests have been in pituitary diseases including growth hormone excess (Acromegaly) and growth hormone deficiency. He has published extensively in growth hormone research and in the secretion of ACTH in normals and in patients with pathologic pituitary/adrenal relationships. He is most proud of his recognition by students as an outstanding teacher for the each of the last 36 years at OHSU.
Stanford University School of Medicine
Laurence Katznelson, MD received his medical degree from the University of California, Los Angeles and performed his internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania, Philadelphia. He then performed a fellowship in endocrinology and metabolism at the Massachusetts General Hospital, Boston. Dr. Katznelson is an Associate Professor of Neurosurgery and Medicine at Stanford University School of Medicine. At Stanford University, he is the Program Director for the Endocrine fellowship training program. He is a member of the Editorial Boards for Pituitary and the Journal of Clinical Endocrinology and Metabolism. Dr. Katznelson is a member of the Special Programs Committee and the Clinical Affairs Core Committee of the Endocrine Society. He has served as an ad hoc member of NIH study sections. Dr. Katznelson is currently Chairman of Membership for the Pituitary Society. Dr. Katznelson has a long standing clinical and research interest in the pathophysiology and treatment of pituitary disease.